搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
pharmaphorum
12 小时
Putting the UK back on the map for clinical trials: NWEH partners with CPRD
“It’s a really exciting time, not just for NWEH, but also for the future of clinical trials in the UK. If successful, this ...
pharmaphorum
15 小时
Transforming pharmacovigilance: The revolutionary impact of generative AI on drug safety
In the era of digital health transformation, generative AI (GenAI) has emerged as a breakthrough technology in ...
pharmaphorum
10 小时
Court sides with EU on decision to revoke Ocaliva's license
Advanz won a temporary reprieve in September after the General Court of the European Union ordered a suspension of the EC's ...
pharmaphorum
13 小时
Kisqali gets early breast cancer approval in Europe
The European Commission has cleared use of CDK4/6 inhibitor Kisqali (ribociclib) to reduce the risk of recurrence in patients ...
pharmaphorum
11 小时
Trump puts final piece in his MAHA puzzle with NIH nominee
Trump has nominated Dr Jay Bhattacharya, a 56-year-old physician and health economist at Stanford University School of ...
pharmaphorum
13 小时
Amgen's big reveal of obesity data falls a little flat
That increased convenience will have to be accompanied by weight loss that is at least as effective as its rivals, and Amgen ...
pharmaphorum
10 小时
EU stands firm on Ocaliva, revoking drug's license
The European Commission revoked the conditional marketing authorisation for Ocaliva (obeticholic acid) earlier this year on ...
pharmaphorum
12 小时
8th Gene Therapy Development Summit
Returning to Boston in March, the 8th Gene Therapy Development Summit, formerly known as the Gene Therapy for Rare Disorders ...
pharmaphorum
12 小时
Neuroscience Innovation Pharma Partnering Summit
Significant breakthroughs in CNS biology, coupled with innovative neuroscience technologies and a more supportive regulatory ...
pharmaphorum
13 小时
10th Innate Killer Summit
Celebrating 10 years as the definitive platform for the NK community, the flagship Innate Killer Summit will unite ...
pharmaphorum
15 小时
NICE backs AZ/Ionis' Wainzua for ATTR polyneuropathy
New guidance from health technology assessment (HTA) agency NICE backs the use of Wainzua (eplontersen) to treat stage 1 or 2 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈